Home › Large Granular Lymphocytic Leukemia › Massachusetts › Boston
Large Granular Lymphocytic Leukemia clinical trials in Boston, MA
4 studies for Large Granular Lymphocytic Leukemia are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
RecruitingPhase 1
- Dana Farber Cancer Institute, Boston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RecruitingPhase 1/2
- Dren Investigational Site, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Large Granular Lymphocytic Leukemia trials in other cities
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.